In recent years the role of diagnostic imaging by pelvic ultrasound in the diagnosis and staging of gynecological cancers has been growing exponentially. Evidence from recent prospective multicenter studies has demonstrated high accuracy for pre-operative locoregional ultrasound staging in gynecological cancers. Therefore, in many leading gynecologic oncology units, ultrasound is implemented next to pelvic MRI as the first-line imaging modality for gynecological cancer. The work herein is a consensus statement on the role of pre-operative imaging by ultrasound and other imaging modalities in gynecological cancer, following European Society guidelines.

Department of Gynecology and Obstetrics A Hospital and University Centre of Coimbra Coimbra Portugal

Department of Gynecology and Obstetrics Hospital de Braga Braga Portugal

Department of Gynecology and Obstetrics Ospedale Policlinico San Martino and University of Genoa Genoa Italy

Department of Obstetrics and Gynecology São Francisco de Xavier Hospital in Lisbon Lisbon Portugal

Gynecologic Oncology Center Department of Gynecology Obstetrics and Neonatology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Mohn Medical Imaging and Visualization Centre Department of Radiology and Department of Clinical Medicine Haukeland University Hospital and the University of Bergen Bergen Norway

Zobrazit více v PubMed

Andreotti RF, Timmerman D, Strachowski LM, et al. . O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee. Radiology 2020;294:168–85. 10.1148/radiol.2019191150 PubMed DOI

Van Calster B, Van Hoorde K, Valentin L, et al. . Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 2014;349:g5920. 10.1136/bmj.g5920 PubMed DOI PMC

Andreotti RF, Timmerman D, Benacerraf BR, et al. . Ovarian-adnexal reporting lexicon for ultrasound: a white paper of the ACR ovarian-adnexal reporting and data system committee. J Am Coll Radiol 2018;15:1415–29. 10.1016/j.jacr.2018.07.004 PubMed DOI

TNM classification of malignant tumours, 8th Edn. 2016.

Eisenhauer EA, Therasse P, Bogaerts J, et al. . New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228–47. 10.1016/j.ejca.2008.10.026 PubMed DOI

Epstein E, Fischerova D, Valentin L, et al. . Ultrasound characteristics of endometrial cancer as defined by International Endometrial Tumor Analysis (IETA) consensus nomenclature: prospective multicenter study. Ultrasound Obstet Gynecol 2018;51:818–28. 10.1002/uog.18909 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/51/6 PubMed DOI

Haldorsen IS, Lura N, Blaakær J, et al. . What is the role of imaging at primary diagnostic work-up in uterine cervical cancer Curr Oncol Rep 2019;21:77. 10.1007/s11912-019-0824-0 PubMed DOI PMC

Christiansen F, Epstein EL, Smedberg E, et al. . Ultrasound image analysis using deep neural networks for discriminating between benign and malignant ovarian tumors: comparison with expert subjective assessment. Ultrasound Obstet Gynecol 2021;57:155–63. 10.1002/uog.23530 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/57/1 PubMed DOI PMC

Oonk MHM, Planchamp F, Baldwin P, et al. . European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer - update 2023. Int J Gynecol Cancer 2023;33:1023–43. 10.1136/ijgc-2023-004486 PubMed DOI PMC

Nout RA, Calaminus G, Planchamp F, et al. . ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer. Int J Gynecol Cancer 2023;33:1185–202. 10.1136/ijgc-2023-004695 PubMed DOI

Cibula D, Raspollini MR, Planchamp F, et al. . ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer - update 2023. Int J Gynecol Cancer 2023;33:649–66. 10.1136/ijgc-2023-004429 PubMed DOI PMC

Concin N, Matias-Guiu X, Vergote I, et al. . ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 2021;31:12–39. 10.1136/ijgc-2020-002230 PubMed DOI

Timmerman D, Planchamp F, Bourne T, et al. . ESGO/ISUOG/IOTA/ESGE consensus statement on pre-operative diagnosis of ovarian tumors. Int J Gynecol Cancer 2021;31:961–82. 10.1136/ijgc-2021-002565 PubMed DOI PMC

Colombo N, Sessa C, du Bois A, et al. . ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer 2019:ijgc-2019-000308. 10.1136/ijgc-2019-000308 PubMed DOI

Testa AC, Ludovisi M, Mascilini F, et al. . Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 2012;39:99–105. 10.1002/uog.10100 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/39/1 PubMed DOI

Fischerova D, Zikan M, Semeradova I, et al. . Ultrasound in preoperative assessment of pelvic and abdominal spread in patients with ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 2017;49:263–74. 10.1002/uog.15942 Available: http://doi.wiley.com/10.1002/uog.2017.49.issue-2 PubMed DOI

Fischerova D, Pinto P, Burgetova A, et al. . Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study). Ultrasound Obstet Gynecol 2022;59:248–62. PubMed

Fischerova D, Garganese G, Reina H, et al. . Terms, definitions and measurements to describe sonographic features of lymph nodes: consensus opinion from the Vulvar International Tumor Analysis (VITA) group . Ultrasound Obstet Gynecol 2021;57:861–79. 10.1002/uog.23617 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/57/6 PubMed DOI

Oonk MHM, Planchamp F, Baldwin P, et al. . European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer. Int J Gynecol Cancer 2017;27:832–7. 10.1097/IGC.0000000000000975 PubMed DOI

Pinto P, Borcinova M, Wiesnerova M, et al. . Op12.05: patient satisfaction with ultrasound, CT and WB-DWI/MRI for preoperative ovarian cancer staging: a multicentre prospective survey. Ultrasound Obstet Gynecol 2023;62:78–9. 10.1002/uog.26546 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/62/S1 DOI

Saini S, Seltzer SE, Bramson RT, et al. . Technical cost of radiologic examinations: analysis across imaging modalities. Radiology 2000;216:269–72. 10.1148/radiology.216.1.r00jl18269 PubMed DOI

Fischerova D, Cibula D, Dundr P, et al. . Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors. Int J Gynecol Cancer 2008;18:833–7. 10.1111/j.1525-1438.2007.01015.x PubMed DOI

Zikan M, Fischerova D, Pinkavova I, et al. . Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound Obstet Gynecol 2010;36:767–72. 10.1002/uog.8803 PubMed DOI

Mascilini F, Moro F, De Leo R, et al. . Intraoperative ultrasound assistance for the surgical removal of lost Intrauterine device. Ultrasound Obstet Gynecol 2019;53:705–6. 10.1002/uog.19167 PubMed DOI

Pinkavova I, Dundr P, Fischerova D, et al. . Intra-operative ultrasound in fertility sparing procedure for cervical cancer (Oc24.04). Ultrasound Obstet Gynecol 2012;40:51. 10.1002/uog.11379 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/40/S1 DOI

Bierig SM, Jones A. Accuracy and cost comparison of ultrasound versus alternative imaging modalities, including CT, MR, PET, and angiography. J Diagnost Med Sonog 2009;25:138–44. 10.1177/8756479309336240 DOI

Eriksson LSE, Lindqvist PG, Flöter Rådestad A, et al. . Transvaginal ultrasound assessment of myometrial and cervical stromal invasion in women with endometrial cancer: interobserver reproducibility among ultrasound experts and gynecologists. Ultrasound Obstet Gynecol 2015;45:476–82. 10.1002/uog.14645 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/45/4 PubMed DOI

Pálsdóttir K, Fridsten S, Blomqvist L, et al. . Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer. Ultrasound Obstet Gynecol 2021;58:773–9. 10.1002/uog.23662 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/58/5 PubMed DOI PMC

Fischerová D, Pesta M, Blazko M, et al. . Oc12.08: observer-reality agreement for tumour spread and prediction non-resectability in ovarian cancer (ISAAC study, imaging study on advanced ovarian cancer). Ultrasound Obstet Gynecol 2023;62:29–30. 10.1002/uog.26402 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/62/S1 DOI

Olawaiye AB, Cuello MA, Rogers LJ. Cancer of the vulva: 2021 update. Int J Gynaecol Obstet 2021;155:7–18. 10.1002/ijgo.13881 PubMed DOI PMC

Nikolić O, Sousa FAE, Cunha TM, et al. . Vulvar cancer staging: guidelines of the European society of Urogenital Radiology (ESUR). Insights Imaging 2021;12:131. 10.1186/s13244-021-01075-6 PubMed DOI PMC

Rogers LJ, Cuello MA. Cancer of the vulva. Int J Gynaecol Obstet 2018;143 Suppl 2:4–13. 10.1002/ijgo.12609 PubMed DOI

Zapardiel I, Iacoponi S, Coronado PJ, et al. . Prognostic factors in patients with vulvar cancer: the VULCAN study. Int J Gynecol Cancer 2020;30:1285–91. 10.1136/ijgc-2019-000526 PubMed DOI

Iacoponi S, Zapardiel I, Diestro MD, et al. . Prognostic factors associated with local recurrence in squamous cell carcinoma of the vulva. J Gynecol Oncol 2013;24:242–8. 10.3802/jgo.2013.24.3.242 PubMed DOI PMC

Olawaiye AB, Cotler J, Cuello MA, et al. . FIGO staging for carcinoma of the vulva: 2021 revision. Int J Gynaecol Obstet 2021;155:43–7. 10.1002/ijgo.13880 PubMed DOI PMC

Gibb RK, Olawaiye AB, Bhosale PR, et al. . Vulva. In: Amin MB, ed. TNM Classification of Malignant Tumours. Switzerland: Springer International Publishing AG Switzerland, 2016.

de Gregorio N, Ebner F, Schwentner L, et al. . The role of preoperative ultrasound evaluation of Inguinal lymph nodes in patients with vulvar malignancy. Gynecol Oncol 2013;131:113–7. 10.1016/j.ygyno.2013.07.103 PubMed DOI

Verri D, Moro F, Fragomeni SM, et al. . The role of ultrasound in the evaluation of Inguinal lymph nodes in patients with vulvar cancer: a systematic review and meta-analysis. Cancers (Basel) 2022;14:3082. 10.3390/cancers14133082 PubMed DOI PMC

Virarkar M, Vulasala SS, Daoud T, et al. . Vulvar cancer: 2021 revised FIGO staging system and the role of imaging. Cancers (Basel) 2022;14:2264. 10.3390/cancers14092264 PubMed DOI PMC

Serrado MA, Horta M, Cunha TM. State of the art in Vulvar cancer imaging. Radiol Bras 2019;52:316–24. 10.1590/0100-3984.2018.0072 PubMed DOI PMC

Angelico G, Santoro A, Inzani F, et al. . Ultrasound-guided FNA cytology of groin lymph nodes improves the management of squamous cell carcinoma of the vulva: results from a comparative cytohistological study. Cancer Cytopathol 2019;127:514–20. 10.1002/cncy.22154 PubMed DOI

Bipat S, Fransen GA, Spijkerboer AM, et al. . Is there a role for magnetic resonance imaging in the evaluation of inguinal lymph node metastases in patients with vulva carcinoma Gynecol Oncol 2006;103:1001–6. 10.1016/j.ygyno.2006.06.009 PubMed DOI

Hawnaur JM, Reynolds K, Wilson G, et al. . Identification of Inguinal lymph node metastases from vulval carcinoma by magnetic resonance imaging: an initial report. Clin Radiol 2002;57:995–1000. 10.1053/crad.2002.1057 PubMed DOI

Kataoka MY, Sala E, Baldwin P, et al. . The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study. Gynecol Oncol 2010;117:82–7. 10.1016/j.ygyno.2009.12.017 PubMed DOI

Singh K, Orakwue CO, Honest H, et al. . Accuracy of magnetic resonance imaging of Inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer 2006;16:1179–83. 10.1111/j.1525-1438.2006.00456.x PubMed DOI

Sohaib SAA, Richards PS, Ind T, et al. . MR imaging of carcinoma of the vulva. AJR Am J Roentgenol 2002;178:373–7. 10.2214/ajr.178.2.1780373 PubMed DOI

Rufini V, Garganese G, Ieria FP, et al. . Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study. Eur J Nucl Med Mol Imaging 2021;48:3303–14. 10.1007/s00259-021-05257-8 PubMed DOI PMC

Lakhman Y, Vargas HA, Reinhold C, et al. . ACR appropriateness criteria® staging and follow-up of vulvar cancer. J Am Coll Radiol 2021;18:S212–28. 10.1016/j.jacr.2021.02.016 PubMed DOI

Sung H, Ferlay J, Siegel RL, et al. . Global cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. 10.3322/caac.21660 PubMed DOI

Board WCoTE . Female genital tumours: International agency for research on cancer. 2020.

Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet 2021;155:19–27. 10.1002/ijgo.13867 PubMed DOI PMC

Beller U, Benedet JL, Creasman WT, et al. . Carcinoma of the vagina. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S29–42. 10.1016/S0020-7292(06)60029-5 PubMed DOI

Gibb RK, Olowaiye AB, Bosale PR, et al. . Vagina. In: Amin MB, ed. AJCC Cancer Staging Manual. Switzerland: Springer International Publishing AG Switzerland, 2016.

Wolfson AH, Reis IM, Portelance L, et al. . Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: a SEER analysis. Gynecol Oncol 2016;141:255–9. 10.1016/j.ygyno.2016.03.009 PubMed DOI

Yang J, Delara R, Magrina J, et al. . Management and outcomes of primary vaginal cancer. Gynecol Oncol 2020;159:456–63. 10.1016/j.ygyno.2020.08.036 PubMed DOI

Prameela CG, Ravind R, Gurram BC, et al. . Prognostic factors in primary vaginal cancer: a single Institute experience and review of literature. J Obstet Gynaecol India 2016;66:363–71. 10.1007/s13224-015-0697-6 PubMed DOI PMC

Rajaram S, Maheshwari A, Srivastava A. Staging for vaginal cancer. Best Pract Res Clin Obstet Gynaecol 2015;29:822–32. 10.1016/j.bpobgyn.2015.01.006 PubMed DOI

Frumovitz M, Gayed IW, Jhingran A, et al. . Lymphatic mapping and sentinel lymph node detection in women with vaginal cancer. Gynecol Oncol 2008;108:478–81. 10.1016/j.ygyno.2007.12.001 PubMed DOI

Gardner CS, Sunil J, Klopp AH, et al. . Primary vaginal cancer: role of MRI in diagnosis, staging and treatment. Br J Radiol 2015;88:20150033. 10.1259/bjr.20150033 PubMed DOI PMC

Lamoreaux WT, Grigsby PW, Dehdashti F, et al. . FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 2005;62:733–7. 10.1016/j.ijrobp.2004.12.011 PubMed DOI

Nout R, Calaminus G, Planchamp F, et al. . ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer. Radiother Oncol 2023;186:109662. 10.1016/j.radonc.2023.109662 PubMed DOI

Olawaiye AB, Baker TP, Washington MK, et al. . The new (version 9) American Joint Committee on Cancer tumor, node, metastasis staging for cervical cancer. CA Cancer J Clin 2021;71:287–98. 10.3322/caac.21663 PubMed DOI

Bhatla N, Berek JS, Cuello Fredes M, et al. . Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019;145:129–35. 10.1002/ijgo.12749 PubMed DOI

Lura N, Wagner-Larsen KS, Forsse D, et al. . What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer Insights Imaging 2022;13:105. 10.1186/s13244-022-01239-y PubMed DOI PMC

Wagner-Larsen KS, Lura N, Salvesen Ø, et al. . Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer. Eur Radiol 2022;32:6444–55. 10.1007/s00330-022-08666-x PubMed DOI PMC

Mitchell DG, Snyder B, Coakley F, et al. . Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup study. J Clin Oncol 2006;24:5687–94. 10.1200/JCO.2006.07.4799 PubMed DOI

Epstein E, Testa A, Gaurilcikas A, et al. . Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial. Gynecol Oncol 2013;128:449–53. 10.1016/j.ygyno.2012.09.025 PubMed DOI

Alcazar JL, García E, Machuca M, et al. . Magnetic resonance imaging and ultrasound for assessing parametrial infiltration in cervical cancer. A systematic review and meta-analysis. Med Ultrason 2020;22:85–91. 10.11152/mu-2361 PubMed DOI

Jurado M, Galván R, Martinez-Monge R, et al. . Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study. World J Surg Oncol 2008;6:126. 10.1186/1477-7819-6-126 PubMed DOI PMC

Testa AC, Di Legge A, De Blasis I, et al. . Imaging techniques for the evaluation of cervical cancer. Best Pract Res Clin Obstet Gynaecol 2014;28:741–68. 10.1016/j.bpobgyn.2014.04.009 PubMed DOI

Qin J, Cheng X, Chen X, et al. . Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma. Ultrasound Obstet Gynecol 2012;39:226–34. 10.1002/uog.10071 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/39/2 PubMed DOI

Alcazar JL, Arribas S, Martinez-Monge R, et al. . Three-dimensional power Doppler ultrasound for predicting response and local recurrence after concomitant chemoradiation therapy for locally advanced carcinoma of the cervix. Int J Gynecol Cancer 2016;26:534–8. 10.1097/IGC.0000000000000641 PubMed DOI

Csutak C, Badea R, Bolboaca SD, et al. . Multimodal endocavitary ultrasound versus MRI and clinical findings in pre- and post-treatment advanced cervical cancer. Med Ultrason 2016;18:75–81. 10.11152/mu.2013.2066.181.csk PubMed DOI

Fischerova D, Zikan M, Pinkavova I, et al. . The role of ultrasound in planning fertility sparing surgery and individual treatment in early stage cervical cancer. Ultrasound Obstet Gynecol 2012;40:51. 10.1002/uog.11380 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/40/S1 DOI

Pálsdóttir K, Fischerova D, Franchi D, et al. . Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound. Ultrasound Obstet Gynecol 2015;45:470–5. 10.1002/uog.14643 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/45/4 PubMed DOI

Cibula D, Kocian R, Plaikner A, et al. . Sentinel lymph node mapping and intraoperative assessment in a prospective, International, multicentre, observational trial of patients with cervical cancer: the SENTIX trial. Eur J Cancer 2020;137:69–80. 10.1016/j.ejca.2020.06.034 PubMed DOI

ClinicalTrials.gov NCT05573451 - General University Hospital P, Charles University CR . Comparison of the Accuracy of US, MRI and PET/CT in the Assessment of LNs in Cervical Cancer. 2023.

Cibula D, Abu-Rustum NR, Dusek L, et al. . Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2012;124:496–501. 10.1016/j.ygyno.2011.11.037 PubMed DOI

Cibula D, Pötter R, Planchamp F, et al. . The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer 2018;28:641–55. 10.1097/IGC.0000000000001216 PubMed DOI

Cibula D, Jarkovsky J, Kocian R, et al. . Magnetic resonance or expert ultrasound in preoperative local staging of patients with early-stage cervical cancer: final results of the SENTIX prospective, single-arm, international trial (CEEGOG CX-01; ENGOT-Cx2). Int J Gynecol Cancer 2023;33:A2.

Stålberg K, Kjølhede P, Bjurberg M, et al. . Risk factors for lymph node metastases in women with endometrial cancer: a population-based, nation-wide register study-on behalf of the Swedish Gynecological Cancer Group. Int J Cancer 2017;140:2693–700. 10.1002/ijc.30707 PubMed DOI

Koskas M, Amant F, Mirza MR, et al. . Cancer of the corpus uteri: 2021 update. Int J Gynecol Obstet 2021;155:45–60. 10.1002/ijgo.13866 Available: https://obgyn.onlinelibrary.wiley.com/toc/18793479/155/S1 PubMed DOI PMC

Berek JS, Matias-Guiu X, Creutzberg C, et al. . FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet 2023;162:383–94. 10.1002/ijgo.14923 PubMed DOI

Paño B, Sebastià C, Ripoll E, et al. . Pathways of lymphatic spread in gynecologic malignancies. Radiographics 2015;35:916–45. 10.1148/rg.2015140086 PubMed DOI

The Cancer Genome Atlas Research Network, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67–73. 10.1038/nature12113 PubMed DOI PMC

León-Castillo A, de Boer SM, Powell ME, et al. . Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on prognosis and benefit from adjuvant therapy. J Clin Oncol 2020;38:3388–97. 10.1200/JCO.20.00549 PubMed DOI PMC

Stewart CJR, Crum CP, McCluggage WG, et al. . Guidelines to aid in the distinction of endometrial and endocervical carcinomas, and the distinction of independent primary carcinomas of the endometrium and adnexa from metastatic spread between these and other sites. Int J Gynecol Pathol 2019;38:S75–92. 10.1097/PGP.0000000000000553 PubMed DOI PMC

Valentin L. Ultrasound deserves to play a prominent role in the diagnosis and management of endometrial cancer. Ultrasound Obstet Gynecol 2014;43:483–7. 10.1002/uog.13371 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/43/5 PubMed DOI

Leone FPG, Timmerman D, Bourne T, et al. . Terms, definitions and measurements to describe the sonographic features of the endometrium and Intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group. Ultrasound Obstet Gynecol 2010;35:103–12. 10.1002/uog.7487 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/35/1 PubMed DOI

Van Den Bosch T, Verbakel JY, Valentin L, et al. . Typical ultrasound features of various endometrial pathologies described using International endometrial tumor analysis (IETA) terminology in women with abnormal uterine bleeding . Ultrasound Obstet Gynecol 2021;57:164–72. 10.1002/uog.22109 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/57/1 PubMed DOI

Di Spiezio Sardo A, Saccone G, Carugno J, et al. . Endometrial biopsy under direct hysteroscopic visualisation versus blind endometrial sampling for the diagnosis of endometrial hyperplasia and cancer: systematic review and meta-analysis. Facts Views Vis Obgyn 2022;14:103–10. 10.52054/FVVO.14.2.023 PubMed DOI PMC

van Hanegem N, Prins MMC, Bongers MY, et al. . The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016;197:147–55. 10.1016/j.ejogrb.2015.12.008 PubMed DOI

Rodolakis A, Scambia G, Planchamp F, et al. . ESGO/ESHRE/ESGE guidelines for the fertility-sparing treatment of patients with endometrial carcinoma Hum Reprod Open 2023;2023:hoac057. 10.1093/hropen/hoac057 PubMed DOI PMC

Green RW, Heremans R, Fischerová D, et al. . Oc19.01 prediction of outcome in endometrial cancer improved by combining traditional with sonographic and demographic parameters: IETA4 cohort follow-up. Ultrasound Obstet Gynecol 2023;62:43–4. 10.1002/uog.26440 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/62/S1 DOI

Epstein E, Blomqvist L. Imaging in endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2014;28:721–39. 10.1016/j.bpobgyn.2014.04.007 PubMed DOI

Fischerova D, Frühauf F, Zikan M, et al. . Factors affecting sonographic preoperative local staging of endometrial cancer. Ultrasound Obstet Gynecol 2014;43:575–85. 10.1002/uog.13248 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/43/5 PubMed DOI

Alcazar JL, Carazo P, Pegenaute L, et al. . Preoperative assessment of cervical involvement in endometrial cancer by transvaginal ultrasound and magnetic resonance imaging: a systematic review and meta-analysis. Ultraschall Med 2023;44:280–9. 10.1055/a-1408-2292 PubMed DOI

Alcázar JL, Gastón B, Navarro B, et al. . Transvaginal ultrasound versus magnetic resonance imaging for preoperative assessment of myometrial infiltration in patients with endometrial cancer: a systematic review and meta-analysis. J Gynecol Oncol 2017;28:e86. 10.3802/jgo.2017.28.e86 PubMed DOI PMC

Christensen JW, Dueholm M, Hansen ES, et al. . Assessment of myometrial invasion in endometrial cancer using three-dimensional ultrasound and magnetic resonance imaging. Acta Obstet Gynecol Scand 2016;95:55–64. 10.1111/aogs.12806 PubMed DOI

Wong M, Amin T, Thanatsis N, et al. . A prospective comparison of the diagnostic accuracies of ultrasound and magnetic resonance imaging in preoperative staging of endometrial cancer. J Gynecol Oncol 2022;33:e22. 10.3802/jgo.2022.33.e22 PubMed DOI PMC

Palmér M, Åkesson Å, Marcickiewicz J, et al. . Accuracy of transvaginal ultrasound versus MRI in the preoperative diagnostics of low-grade endometrial cancer (PODEC) study: a prospective multicentre study. Clin Radiol 2023;78:70–9. 10.1016/j.crad.2022.09.118 PubMed DOI

Antonsen SL, Jensen LN, Loft A, et al. . MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. Gynecol Oncol 2013;128:300–8. 10.1016/j.ygyno.2012.11.025 PubMed DOI

Rodríguez-Trujillo A, Martínez-Serrano MJ, Martínez-Román S, et al. . Preoperative assessment of myometrial invasion in endometrial cancer by 3D ultrasound and diffusion-weighted magnetic resonance imaging: a comparative study. Int J Gynecol Cancer 2016;26:1105–10. 10.1097/IGC.0000000000000724 PubMed DOI

Haldorsen IS, Salvesen HB. What is the best preoperative imaging for endometrial cancer? Curr Oncol Rep 2016;18:25. 10.1007/s11912-016-0506-0 PubMed DOI PMC

Mariani A, Webb MJ, Keeney GL, et al. . Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary Am J Obstet Gynecol 2000;182:1506–19. 10.1067/mob.2000.107335 PubMed DOI

Ytre-Hauge S, Husby JA, Magnussen IJ, et al. . Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas. Int J Gynecol Cancer 2015;25:459–66. 10.1097/IGC.0000000000000367 PubMed DOI PMC

Dybvik JA, Fasmer KE, Ytre-Hauge S, et al. . MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer. Insights Imaging 2022;13:1. 10.1186/s13244-021-01133-z PubMed DOI PMC

Verbakel JY, Mascilini F, Wynants L, et al. . Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Wndometrial Tumor Analysis)-4 cohort. Ultrasound Obstet Gynecol 2020;55:115–24. 10.1002/uog.20374 PubMed DOI

Fasmer KE, Gulati A, Dybvik JA, et al. . Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer-time to revisit current imaging guidelines? Eur Radiol 2023;33:221–32. 10.1007/s00330-022-08949-3 PubMed DOI PMC

Hu J, Zhang K, Yan Y, et al. . Diagnostic accuracy of preoperative (18)F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 2019;300:519–29. 10.1007/s00404-019-05207-8 PubMed DOI

Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, et al. . High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med 2016;57:879–85. 10.2967/jnumed.115.170597 PubMed DOI

Raimond E, Ballester M, Hudry D, et al. . Impact of sentinel lymph node biopsy on the therapeutic management of early-stage endometrial cancer: results of a retrospective multicenter study. Gynecol Oncol 2014;133:506–11. 10.1016/j.ygyno.2014.03.019 PubMed DOI

Prat J, Olowaiye AB, Bermudez A, et al. . Ovary, Fallopian tube, and primary peritoneal carcinoma. In: Amin MB, ed. AJCC Cancer Staging Manual. Switzerland: Springer International Publishing AG Switzerland, 2016.

Prat J, FIGO Committee on Gynecologic Oncology . Staging classification for cancer of the ovary, Fallopian tube, and peritoneum. Int J Gynaecol Obstet 2014;124:1–5. 10.1016/j.ijgo.2013.10.001 PubMed DOI

Woo YL, Kyrgiou M, Bryant A, et al. . Centralisation of services for gynaecological cancers - a Cochrane systematic review. Gynecol Oncol 2012;126:286–90. 10.1016/j.ygyno.2012.04.012 PubMed DOI

Timmerman D, Van Calster B, Testa A, et al. . Predicting the risk of malignancy in adnexal masses based on the simple rules from the International Ovarian Tumor Analysis Group. Am J Obstet Gynecol 2016;214:424–37. 10.1016/j.ajog.2016.01.007 PubMed DOI

Landolfo C, Bourne T, Froyman W, et al. . Benign descriptors and adnex in two-step strategy to estimate risk of malignancy in ovarian tumors: retrospective validation on IOTA 5 multicenter cohort. Ultrasound Obstet Gynecol 2023;61:231–42. 10.1002/uog.26080 Available: https://obgyn.onlinelibrary.wiley.com/toc/14690705/61/2 PubMed DOI PMC

Timmerman D, Valentin L, Bourne TH, et al. . Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) group. Ultrasound Obstet Gynecol 2000;16:500–5. 10.1046/j.1469-0705.2000.00287.x PubMed DOI

Pinto P, Burgetova A, Cibula D, et al. . Prediction of surgical outcome in advanced ovarian cancer by imaging and laparoscopy: a narrative review. Cancers (Basel) 2023;15:1904. 10.3390/cancers15061904 PubMed DOI PMC

Moruzzi MC, Bolomini G, Esposito R, et al. . Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer. Am J Obstet Gynecol 2022;227:601. 10.1016/j.ajog.2022.05.029 PubMed DOI

Alcázar JL, Caparros M, Arraiza M, et al. . Pre-operative assessment of intra-abdominal disease spread in epithelial ovarian cancer: a comparative study between ultrasound and computed tomography. Int J Gynecol Cancer 2019;29:227–33. 10.1136/ijgc-2018-000066 PubMed DOI

Vargas HA, Huang EP, Lakhman Y, et al. . Radiogenomics of high-grade serous ovarian cancer: multireader multi-institutional study from the cancer genome Atlas ovarian cancer imaging research group. Radiology 2017;285:482–92. 10.1148/radiol.2017161870 PubMed DOI PMC

Michielsen K, Dresen R, Vanslembrouck R, et al. . Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer 2017;83:88–98. 10.1016/j.ejca.2017.06.010 PubMed DOI

Kumar Dhingra V, Kand P, Basu S. Impact of FDG-PET and -PET/CT imaging in the clinical decision-making of ovarian carcinoma: an evidence-based approach. Womens Health (Lond) 2012;8:191–203. 10.2217/whe.11.91 PubMed DOI

De Iaco P, Musto A, Orazi L, et al. . FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy. Eur J Radiol 2011;80:e98–103. 10.1016/j.ejrad.2010.07.013 PubMed DOI

Pinto P, Chiappa V, Alcazar JL, et al. . 2022-RA-891-ESGO preoperative assessment of non-resectability in patients with ovarian cancer using imaging (ISAAC study) – an interim analysis. ESGO 2022 Congress 2022. 10.1136/ijgc-2022-ESGO.584 DOI

Fischerova D, Burgetova A. Imaging techniques for the evaluation of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2014;28:697–720. 10.1016/j.bpobgyn.2014.04.006 PubMed DOI

Fischerova D, Cibula D. Ultrasound in gynecological cancer: is it time for re-evaluation of its uses Curr Oncol Rep 2015;17:28. 10.1007/s11912-015-0449-x PubMed DOI

González-Martín A, Harter P, Leary A, et al. . Newly diagnosed and relapsed epithelial ovarian cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 2023;34:833–48. 10.1016/j.annonc.2023.07.011 PubMed DOI

Harter P, Sehouli J, Lorusso D, et al. . A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 2019;380:822–32. 10.1056/NEJMoa1808424 PubMed DOI